Literature DB >> 15896460

Cyclin D1 G870A polymorphism and squamous cell carcinoma of the uterine cervix in Korean women.

Yong-Tark Jeon1, Jae Weon Kim, Jung Han Song, Noh-Hyun Park, Yong-Sang Song, Soon-Beom Kang, Hyo-Pyo Lee.   

Abstract

Though many investigators have reported relationships between the CCND1 polymorphism and susceptibility to various carcinomas, to our knowledge, no report has been issued concerning its relationship with uterine cervical cancer. Thus, we undertook this study to investigate the association between CCND1 polymorphisms and susceptibility to cervical cancer in Korean women. This study was carried on 222 patients with squamous cell carcinoma of uterine cervix and on 314 normal controls. CCND1 genotyping was determined by polymerase chain reaction and restriction fragment length polymorphism. The allelic frequencies of the cases (A, 0.53; G, 0.47) were not significantly different from those of the controls (A, 0.49; G, 0.51) (P=0.238). Regression analysis after adjusting for age showed that the CCND1 G870A genotypes are not related to the risk of squamous cell carcinoma of the uterine cervix. Our findings suggest that the CCND1 polymorphism is not associated with an increased risk of squamous cell carcinoma of uterine cervix in Korean women.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15896460     DOI: 10.1016/j.canlet.2004.12.024

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  7 in total

1.  Distribution of CCND1 A870G polymorphism in patients with advanced uterine cervical carcinoma.

Authors:  Teresa Warchoł; Lukasz Kruszyna; Margarita Lianeri; Andrzej Roszak; Paweł P Jagodziński
Journal:  Pathol Oncol Res       Date:  2010-08-03       Impact factor: 3.201

2.  CCND1 G870A polymorphism and cervical cancer risk: a case-control study and meta-analysis.

Authors:  Jing Ni; Meilin Wang; Miaomiao Wang; Shilong Fu; Delan Zhou; Zhengdong Zhang; Suping Han
Journal:  J Cancer Res Clin Oncol       Date:  2010-05-15       Impact factor: 4.553

3.  Cyclin D1 (G870A) polymorphism and risk of cervix cancer: a case control study in north Indian population.

Authors:  Kaur Satinder; Sobti Ranbir Chander; Kaur Pushpinder; Gupta Indu; Jain Veena
Journal:  Mol Cell Biochem       Date:  2008-06-12       Impact factor: 3.396

4.  Cyclin D1 (CCND1) G870A polymorphisms and cervical cancer susceptibility: a meta-analysis based on ten case-control studies.

Authors:  Yongfu Wu; Hui Fu; Hanbin Zhang; Haohai Huang; Miao Chen; Li Zhang; Huiling Yang; Dongyun Qin
Journal:  Tumour Biol       Date:  2014-04-16

5.  Regulation of glioblastoma progression by cord blood stem cells is mediated by downregulation of cyclin D1.

Authors:  Kiran Kumar Velpula; Venkata Ramesh Dasari; Andrew J Tsung; Christopher S Gondi; Jeffrey D Klopfenstein; Sanjeeva Mohanam; Jasti S Rao
Journal:  PLoS One       Date:  2011-03-24       Impact factor: 3.240

6.  The Effect of HER2 Single Nucleotide Polymorphisms on Cervical Cancer Susceptibility and Survival in a Chinese Population.

Authors:  Yan Gao; Xiuwu Tang; Jieqin Cao; Rong Rong; Zhengmin Yu; Yang Liu; Yan Lu; Xiaowen Liu; Lei Han; Jiting Liu; Jun Zhang; Ming Xu; Fang Liu
Journal:  J Cancer       Date:  2019-01-01       Impact factor: 4.207

7.  Association between cyclin D1 G870A polymorphism and cervical cancer risk: a cumulative meta-analysis involving 2,864 patients and 3,898 controls.

Authors:  Yuan-Yuan Hu; Rong Zheng; Chong Guo; Yu-Ming Niu
Journal:  Diagn Pathol       Date:  2014-09-10       Impact factor: 2.644

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.